Treace Medical Concepts (TMCI) is jumping 7.5% after investment bank BTIG upgraded the shares to Buy from Neutral. Why BTIG ...
Concepts Inc (NASDAQ:TMCI) received an upgrade from BTIG, with analyst Ryan Zimmerman changing the stock rating from Neutral to Buy and setting a new price target of $16.00. This upgrade comes after a ...
BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...
BTIG analyst Ryan Zimmerman upgraded Treace Medical Concepts (TMCI – Research Report) to a Buy today and set a price target of $16.00. The ...
PONTE VEDRA, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and ...
Treace Medical Concepts, Inc.’s TMCI share price has surged by 10.21%, which has investors questioning if this is right time ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
NDAQ:TMCI) The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Treace Medical Concepts, Inc. For Securities Law Violations ...
The global Bunion Surgery Market, valued at US$437.8 million in 2023, is forecasted to grow at a robust CAGR of 5.7%, reaching US$458.4 ...
John T. Treace, the CEO of Treace Medical Concepts, Inc. (NASDAQ:TMCI), has recently purchased additional shares of the company's common stock, according to a new SEC filing. On... ByInvesting.com • ...
Treace Medical Concepts Trading Up 5.6 % NASDAQ TMCI opened at $8.71 on Friday. Treace Medical Concepts, Inc. has a one year low of $3.92 and a one year high of $15.98. The firm has a market cap ...